Burn injury reduces neutrophil directional migration speed in microfluidic devices

Kathryn L Butler, Vijayakrishnan Ambravaneswaran, Nitin Agrawal, Maryelizabeth Bilodeau, Mehmet Toner, Ronald G Tompkins, Shawn Fagan, Daniel Irimia, Kathryn L Butler, Vijayakrishnan Ambravaneswaran, Nitin Agrawal, Maryelizabeth Bilodeau, Mehmet Toner, Ronald G Tompkins, Shawn Fagan, Daniel Irimia

Abstract

Thermal injury triggers a fulminant inflammatory cascade that heralds shock, end-organ failure, and ultimately sepsis and death. Emerging evidence points to a critical role for the innate immune system, and several studies had documented concurrent impairment in neutrophil chemotaxis with these post-burn inflammatory changes. While a few studies suggest that a link between neutrophil motility and patient mortality might exist, so far, cumbersome assays have prohibited exploration of the prognostic and diagnostic significance of chemotaxis after burn injury. To address this need, we developed a microfluidic device that is simple to operate and allows for precise and robust measurements of chemotaxis speed and persistence characteristics at single-cell resolution. Using this assay, we established a reference set of migration speed values for neutrophils from healthy subjects. Comparisons with samples from burn patients revealed impaired directional migration speed starting as early as 24 hours after burn injury, reaching a minimum at 72-120 hours, correlated to the size of the burn injury and potentially serving as an early indicator for concurrent infections. Further characterization of neutrophil chemotaxis using this new assay may have important diagnostic implications not only for burn patients but also for patients afflicted by other diseases that compromise neutrophil functions.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Overview of the neutrophil chemotaxis…
Figure 1. Overview of the neutrophil chemotaxis device.
a. Microfluidic devices mounted on glass slides are observed on a microscope stage. In this picture, six chemotaxis devices are aligned side by side on the same glass slide. The left most device has inlet and outlet tubing attached and is filled with green fluorescent dye. b. Schematic of the microfluidic device. The device consists of a larger main channel and an orthogonal array of smaller channels. In the first step, the whole device, including the side channels, is primed with the chemoattractant solution. In the second step, neutrophils suspended in buffer are introduced in the main channel, washing out the chemoattractant from the main channel. The chemoattractant gradient is established by diffusion, in the longitudinal direction of the side channels, between the end of the side channels filled with chemoattractant and the main channel filled with buffer. Neutrophils inside the main channel follow a chemoattractant gradient and enter an array of side channels, where their chemotaxis migration speed is measured.
Figure 2. Visualization of the chemical gradients…
Figure 2. Visualization of the chemical gradients along the side channels.
a. Linear gradients, formed along the side channels, were imaged using fluorescent dyes of molecular weight comparable with that of the chemoattractant. Starting immediately after replacing the solution in the main channel with buffer, quantitative fluorescence was measured along the array of side channels at 10, 30 and 60 minutes. These measurements demonstrate the relative stability of the linear chemoattractant gradient over time. b. At 30 minutes after introducing the buffer, a linear gradient of fluorescent dye can be visualized along the side channels. The height of the main channel (to the left) is larger that that of the side channels and accounts for the apparent higher fluorescence of the main channel compared to the side channels.
Figure 3. Neutrophil migration inside the array…
Figure 3. Neutrophil migration inside the array of channels.
a. Neutrophils enter the array of channels and move along the channels towards higher concentrations of chemoattractant – see also Movie S1. b. Displacement of neutrophils vs. time inside the array of channels. For the first 10 minutes after entering the side channels neutrophil display remarkably uniform migration speed. Insert shows the distribution of average speed of migration for 800 neutrophils from one healthy donor.
Figure 4. Neutrophil motility in healthy donors.
Figure 4. Neutrophil motility in healthy donors.
a. Average neutrophil motility in 18 healthy donors. Samples were rearranged in decreasing order of the average motilities. Bars represent standard error of the mean. The motility of at least 50 neutrophils was calculated for each sample. b. Validation of the repeatability of neutrophil motility. Two samples from the same healthy donors were collected at two weeks time interval and neutrophil migration speed measured in the microfluidic devices. c. Distribution of average values for neutrophil motility with the age of healthy donors. No significant changes in neutrophil motility were observed with increasing age of the healthy volunteers. No significant differences were observed between female and male donors (filled and empty dots, respectively).
Figure 5. Correlations between neutrophil motility and…
Figure 5. Correlations between neutrophil motility and clinical parameters in burn patients.
a. We observed significant correlations between neutrophil motility at 72 hours after burn injury and total burn surface area (R2 = 0.6). b. No significant correlation was found between neutrophil motility and the temperature in burn patients (R2 = 0.2). Samples from the same patient are coded using the same symbol.
Figure 6. Correlations between neutrophil motility and…
Figure 6. Correlations between neutrophil motility and neutrophil counts in burn patients.
a. No significant correlation was found between neutrophil motility and the absolute neutrophil count (R2 = 0.2). b. Also, there was no significant correlation between average neutrophil motility and percentage of band cells in the neutrophil population (R2 = 0.01).
Figure 7. Changes in neutrophil motility in…
Figure 7. Changes in neutrophil motility in burn patients.
Average neutrophil motility in individual patients was measured at 48 hours intervals after admission to the hospital. Lower values for neutrophil migration speed compared to healthy volunteers (dashed gray line) were recorded as early as 24 hours after burn injury for the majority of the patients. Insert shows the changes in average neutrophil migration speed for all patients, with respect to the time of injury.

References

    1. White CE, Renz EM. Advances in surgical care: management of severe burn injury. Crit Care Med. 2008;36(7) Suppl:S318–324.
    1. Salinas J, Drew G, Gallagher J, Cancio LC, Wolf SE, et al. Closed-loop and decision-assist resuscitation of burn patients. J Trauma. 2008;64(4) Suppl:S321–332.
    1. Saffle JI. The phenomenon of "fluid creep" in acute burn resuscitation. J Burn Care Res. 2007;28(3):382–395.
    1. Ipaktchi K, Arbabi S. Advances in burn critical care. Crit Care Med. 2006;34(9) Suppl:S239–244.
    1. Ong YS, Samuel M, Song C. Meta-analysis of early excision of burns. Burns. 2006;32(2):145–150.
    1. Tompkins RG, Remensnyder JP, Burke JF, Tompkins DM, Hilton JF, et al. Significant reductions in mortality for children with burn injuries through the use of prompt eschar excision. Ann Surg. 1988;208(5):577–585.
    1. Herndon DN, Barrow RE, Rutan RL, Rutan TC, Desai MH, et al. A comparison of conservative versus early excision. Therapies in severely burned patients. Ann Surg. 1989;209(5):547–552; discussion 552-543.
    1. Xiao-Wu W, Herndon DN, Spies M, Sanford AP, Wolf SE. Effects of delayed wound excision and grafting in severely burned children. Arch Surg. 2002;137(9):1049–1054.
    1. Pereira C, Murphy K, Jeschke M, Herndon DN. Post burn muscle wasting and the effects of treatments. Int J Biochem Cell Biol. 2005;37(10):1948–1961.
    1. Branski LK, Herndon DN, Barrow RE, Kulp GA, Klein GL, et al. Randomized Controlled Trial to Determine the Efficacy of Long-Term Growth Hormone Treatment in Severely Burned Children. Ann Surg 2009
    1. Pereira CT, Herndon DN. The pharmacologic modulation of the hypermetabolic response to burns. Adv Surg. 2005;39:245–261.
    1. O'Keefe GE, Hunt JL, Purdue GF. An evaluation of risk factors for mortality after burn trauma and the identification of gender-dependent differences in outcomes. J Am Coll Surg. 2001;192(2):153–160.
    1. Williams FN, Herndon DN, Hawkins HK, Lee JO, Cox RA, et al. The leading causes of death after burn injury in a single pediatric burn center. Crit Care. 2009;13(6):R183.
    1. D'Avignon LC, Hogan BK, Murray CK, Loo FL, Hospenthal DR, et al. Contribution of bacterial and viral infections to attributable mortality in patients with severe burns: An autopsy series. Burns
    1. Greenhalgh DG, Saffle JR, Holmes JH, 4th, Gamelli RL, Palmieri TL, et al. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res. 2007;28(6):776–790.
    1. Warden GD, Mason AD, Jr, Pruitt BA., Jr Evaluation of leukocyte chemotaxis in vitro in thermally injured patients. J Clin Invest. 1974;54(4):1001–1004.
    1. Warden GD, Mason AD, Jr, Pruitt BA., Jr Suppression of leukocyte chemotaxis in vitro by chemotherapeutic agents used in the management of thermal injuries. Ann Surg. 1975;181(3):363–369.
    1. Kim Y, Goldstein E, Lippert W, Brofeldt T, Donovan R. Polymorphonuclear leucocyte motility in patients with severe burns. Burns. 1989;15(2):93–97.
    1. Bjornson AB, Somers SD. Down-regulation of chemotaxis of polymorphonuclear leukocytes following thermal injury involves two distinct mechanisms. J Infect Dis. 1993;168(1):120–127.
    1. Hasslen SR, Nelson RD, Ahrenholz DH, Solem LD. Thermal injury, the inflammatory process, and wound dressing reduce human neutrophil chemotaxis to four attractants. J Burn Care Rehabil. 1993;14(3):303–309.
    1. Manktelow A, Meyer AA. Lack of correlation between decreased chemotaxis and susceptibility to infection in burned rats. J Trauma. 1986;26(2):143–148.
    1. Solomkin JS, Nelson RD, Chenoweth DE, Solem LD, Simmons RL. Regulation of neutrophil migratory function in burn injury by complement activation products. Ann Surg. 1984;200(6):742–746.
    1. Adams JM, Hauser CJ, Livingston DH, Lavery RF, Fekete Z, et al. Early trauma polymorphonuclear neutrophil responses to chemokines are associated with development of sepsis, pneumonia, and organ failure. J Trauma. 2001;51(3):452–456; discussion 456-457.
    1. Bjerknes R, Vindenes H, Laerum OD. Altered neutrophil functions in patients with large burns. Blood Cells. 1990;16(1):127–141; discussion 142-123.
    1. Deitch EA, Lu Q, Xu DZ, Specian RD. Effect of local and systemic burn microenvironment on neutrophil activation as assessed by complement receptor expression and morphology. J Trauma. 1990;30(3):259–268.
    1. Moore FD, Jr, Davis C, Rodrick M, Mannick JA, Fearon DT. Neutrophil activation in thermal injury as assessed by increased expression of complement receptors. N Engl J Med. 1986;314(15):948–953.
    1. Nwariaku FE, Mileski WJ, Lightfoot E, Jr, Sikes PJ, Lipsky PE. Alterations in leukocyte adhesion molecule expression after burn injury. J Trauma. 1995;39(2):285–288.
    1. Mileski WJ, Rothlien R, Lipsky P. Interference with the function of leukocyte adhesion molecules by monoclonal antibodies: a new approach to burn injury. Eur J Pediatr Surg. 1994;4(4):225–230.
    1. Mileski W, Gates B, Sigman A, Sikes P, Atiles L, et al. Inhibition of leukocyte adherence in a rabbit model of major thermal injury. J Burn Care Rehabil. 1993;14(6):610–616.
    1. Babcock GF, Alexander JW, Warden GD. Flow cytometric analysis of neutrophil subsets in thermally injured patients developing infection. Clin Immunol Immunopathol. 1990;54(1):117–125.
    1. Solomkin JS. Neutrophil disorders in burn injury: complement, cytokines, and organ injury. J Trauma. 1990;30(12) Suppl:S80–85.
    1. Mileski WJ, Sikes P, Atiles L, Lightfoot E, Lipsky P, et al. Inhibition of leukocyte adherence and susceptibility to infection. J Surg Res. 1993;54(4):349–354.
    1. Ransjo U, Forsgren A, Arturson G. Neutrophil leucocyte functions and wound bacteria in burn patients. Burns. 1977;3(3):171–178.
    1. Cheng X, Irimia D, Dixon M, Sekine K, Demirci U, et al. A microfluidic device for practical label-free CD4(+) T cell counting of HIV-infected subjects. Lab Chip. 2007;7(2):170–178.
    1. Russom A, Sethu P, Irimia D, Mindrinos MN, Calvano SE, et al. Microfluidic leukocyte isolation for gene expression analysis in critically ill hospitalized patients. Clin Chem. 2008;54(5):891–900.
    1. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007;450(7173):1235–1239.
    1. Li Jeon N, Baskaran H, Dertinger SK, Whitesides GM, Van de Water L, et al. Neutrophil chemotaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device. Nat Biotechnol. 2002;20(8):826–830.
    1. Lin F, Nguyen CM, Wang SJ, Saadi W, Gross SP, et al. Neutrophil migration in opposing chemoattractant gradients using microfluidic chemotaxis devices. Ann Biomed Eng. 2005;33(4):475–482.
    1. Irimia D, Liu SY, Tharp WG, Samadani A, Toner M, et al. Microfluidic system for measuring neutrophil migratory responses to fast switches of chemical gradients. Lab Chip. 2006;6(2):191–198.
    1. Frevert CW, Boggy G, Keenan TM, Folch A. Measurement of cell migration in response to an evolving radial chemokine gradient triggered by a microvalve. Lab Chip. 2006;6(7):849–856.
    1. Abhyankar VV, Toepke MW, Cortesio CL, Lokuta MA, Huttenlocher A, et al. A platform for assessing chemotactic migration within a spatiotemporally defined 3D microenvironment. Lab Chip. 2008;8(9):1507–1515.
    1. Tharp WG, Yadav R, Irimia D, Upadhyaya A, Samadani A, et al. Neutrophil chemorepulsion in defined interleukin-8 gradients in vitro and in vivo. J Leukoc Biol. 2006;79(3):539–554.
    1. Agrawal N, Toner M, Irimia D. Neutrophil migration assay from a drop of blood. Lab Chip. 2008;8(12):2054–2061.
    1. Kasuga K, Yang R, Porter TF, Agrawal N, Petasis NA, et al. Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J Immunol. 2008;181(12):8677–8687.
    1. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med. 1962;115:453–466.
    1. Zigmond SH. Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors. J Cell Biol. 1977;75(2 Pt 1):606–616.
    1. Zicha D, Dunn GA, Brown AF. A new direct-viewing chemotaxis chamber. J Cell Sci. 1991;99 (Pt 4):769–775.
    1. Abhyankar VV, Lokuta MA, Huttenlocher A, Beebe DJ. Characterization of a membrane-based gradient generator for use in cell-signaling studies. Lab Chip. 2006;6(3):389–393.
    1. Gerisch G, Keller HU. Chemotactic reorientation of granulocytes stimulated with micropipettes containing fMet-Leu-Phe. J Cell Sci. 1981;52:1–10.
    1. Lin F, Nguyen CM, Wang SJ, Saadi W, Gross SP, et al. Effective neutrophil chemotaxis is strongly influenced by mean IL-8 concentration. Biochem Biophys Res Commun. 2004;319(2):576–581.
    1. Walker GM, Sai J, Richmond A, Stremler M, Chung CY, et al. Effects of flow and diffusion on chemotaxis studies in a microfabricated gradient generator. Lab Chip. 2005;5(6):611–618.
    1. Hartman RS, Lau K, Chou W, Coates TD. The fundamental motor of the human neutrophil is not random: evidence for local non-Markov movement in neutrophils. Biophys J. 1994;67(6):2535–2545.
    1. Irimia D, Charras G, Agrawal N, Mitchison T, Toner M. Polar stimulation and constrained cell migration in microfluidic channels. Lab Chip. 2007;7(12):1783–1790.
    1. Malawista SE, de Boisfleury Chevance A. Random locomotion and chemotaxis of human blood polymorphonuclear leukocytes (PMN) in the presence of EDTA: PMN in close quarters require neither leukocyte integrins nor external divalent cations. Proc Natl Acad Sci U S A. 1997;94(21):11577–11582.
    1. de Chalain TM, Bracher M, Linley W, Gerneke D, Hickman R. Cytoskeletal actin: the influence of major burns on neutrophil structure and function. Burns. 1994;20(5):416–421.
    1. Alam HB, Rhee P. New developments in fluid resuscitation. Surg Clin North Am. 2007;87(1):55–72, vi.
    1. Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma. 2003;54(5):908–914.
    1. Murray CK, Hoffmaster RM, Schmit DR, Hospenthal DR, Ward JA, et al. Evaluation of white blood cell count, neutrophil percentage, and elevated temperature as predictors of bloodstream infection in burn patients. Arch Surg. 2007;142(7):639–642.
    1. Lakshman R, Finn A. Neutrophil disorders and their management. J Clin Pathol. 2001;54(1):7–19.
    1. Nelson RD, Quie PG, Simmons RL. Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol. 1975;115(6):1650–1656.
    1. Liu Y, Sai J, Richmond A, Wikswo JP. Microfluidic switching system for analyzing chemotaxis responses of wortmannin-inhibited HL-60 cells. Biomed Microdevices. 2008;10(4):499–507.
    1. Cheng SY, Heilman S, Wasserman M, Archer S, Shuler ML, et al. A hydrogel-based microfluidic device for the studies of directed cell migration. Lab Chip. 2007;7(6):763–769.
    1. Kim D, Lokuta MA, Huttenlocher A, Beebe DJ. Selective and tunable gradient device for cell culture and chemotaxis study. Lab Chip. 2009;9(12):1797–1800.
    1. Chung BG, Lin F, Jeon NL. A microfluidic multi-injector for gradient generation. Lab Chip. 2006;6(6):764–768.
    1. Saadi W, Rhee SW, Lin F, Vahidi B, Chung BG, et al. Generation of stable concentration gradients in 2D and 3D environments using a microfluidic ladder chamber. Biomed Microdevices. 2007;9(5):627–635.
    1. Keenan TM, Frevert CW, Wu A, Wong V, Folch A. A new method for studying gradient-induced neutrophil desensitization based on an open microfluidic chamber. Lab Chip. 2010;10(1):116–122.

Source: PubMed

3
Iratkozz fel